Wells Fargo’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $248K | Sell |
62,724
-72,680
| -54% | -$366K | ﹤0.01% | 4580 |
|
|
2025
Q4 | $917K | Buy |
135,404
+29,897
| +28% | +$210K | ﹤0.01% | 4037 |
|
|
2025
Q3 | $736K | Buy |
105,507
+12,532
| +13% | +$87.1K | ﹤0.01% | 4024 |
|
|
2025
Q2 | $568K | Sell |
92,975
-42,914
| -32% | -$285K | ﹤0.01% | 4048 |
|
|
2025
Q1 | $1.03M | Buy |
135,889
+65,842
| +94% | +$550K | ﹤0.01% | 3635 |
|
|
2024
Q4 | $674K | Sell |
70,047
-110,595
| -61% | -$862K | ﹤0.01% | 3982 |
|
|
2024
Q3 | $1.07M | Sell |
180,642
-5,073
| -3% | -$33.6K | ﹤0.01% | 3505 |
|
|
2024
Q2 | $1.29M | Buy |
185,715
+128,158
| +223% | +$901K | ﹤0.01% | 3319 |
|
|
2024
Q1 | $443K | Sell |
57,557
-5,771
| -9% | -$46.4K | ﹤0.01% | 3973 |
|
|
2023
Q4 | $555K | Sell |
63,328
-38,994
| -38% | -$286K | ﹤0.01% | 3791 |
|
|
2023
Q3 | $746K | Buy |
102,322
+3,472
| +4% | +$25.9K | ﹤0.01% | 3525 |
|
|
2023
Q2 | $653K | Buy |
98,850
+9,574
| +11% | +$48.8K | ﹤0.01% | 3759 |
|
|
2023
Q1 | $304K | Buy |
89,276
+60,218
| +207% | +$233K | ﹤0.01% | 4172 |
|
|
2022
Q4 | $80.8K | Buy |
29,058
+7,177
| +33% | +$21.5K | ﹤0.01% | 4640 |
|
|
2022
Q3 | $63K | Sell |
21,881
-7
| -0% | -$25 | ﹤0.01% | 4841 |
|
|
2022
Q2 | $76K | Sell |
21,888
-182,928
| -89% | -$716K | ﹤0.01% | 4807 |
|
|
2022
Q1 | $966K | Sell |
204,816
-87,113
| -30% | -$426K | ﹤0.01% | 3928 |
|
|
2021
Q4 | $1.76M | Buy |
291,929
+8,843
| +3% | +$61.4K | ﹤0.01% | 3620 |
|
|
2021
Q3 | $1.72M | Buy |
283,086
+257,988
| +1,028% | +$2.91M | ﹤0.01% | 3796 |
|
|
2021
Q2 | $314K | Buy |
25,098
+8,115
| +48% | +$87.9K | ﹤0.01% | 4849 |
|
|
2021
Q1 | $175K | Buy |
16,983
+3,947
| +30% | +$38.1K | ﹤0.01% | 5220 |
|
|
2020
Q4 | $119K | Buy |
+13,036
| New | +$93.8K | ﹤0.01% | 5290 |
|
|
2018
Q4 | – | Sell |
-1,108,911
| Closed | -$6.85M | – | 6528 |
|
|
2018
Q3 | $6.85M | Buy |
1,108,911
+349,477
| +46% | +$1.58M | ﹤0.01% | 2388 |
|
|
2018
Q2 | $4.85M | Sell |
759,434
-347,671
| -31% | -$2.47M | ﹤0.01% | 2712 |
|
|
2018
Q1 | $7.72M | Buy |
1,107,105
+153,715
| +16% | +$1.79M | ﹤0.01% | 2240 |
|
|
2017
Q4 | $12M | Buy |
953,390
+238,110
| +33% | +$2.9M | ﹤0.01% | 1864 |
|
|
2017
Q3 | $8.5M | Buy |
715,280
+37,743
| +6% | +$560K | ﹤0.01% | 2100 |
|
|
2017
Q2 | $10.1M | Buy |
677,537
+206,406
| +44% | +$2.75M | ﹤0.01% | 1894 |
|
|
2017
Q1 | $4.49M | Buy |
471,131
+41,028
| +10% | +$346K | ﹤0.01% | 2514 |
|
|
2016
Q4 | $3.81M | Sell |
430,103
-664,681
| -61% | -$5.97M | ﹤0.01% | 2618 |
|
|
2016
Q3 | $9.39M | Buy |
1,094,784
+60,415
| +6% | +$478K | ﹤0.01% | 1803 |
|
|
2016
Q2 | $8.25M | Sell |
1,034,369
-59,892
| -5% | -$466K | ﹤0.01% | 1972 |
|
|
2016
Q1 | $9.56M | Buy |
1,094,261
+52,715
| +5% | +$438K | ﹤0.01% | 1848 |
|
|
2015
Q4 | $9.76M | Buy |
1,041,546
+169,102
| +19% | +$1.47M | ﹤0.01% | 1856 |
|
|
2015
Q3 | $8.42M | Buy |
872,444
+2,732
| +0.3% | +$28.8K | ﹤0.01% | 1939 |
|
|
2015
Q2 | $10.1M | Buy |
869,712
+491,356
| +130% | +$5.06M | ﹤0.01% | 1908 |
|
|
2015
Q1 | $3.94M | Buy |
378,356
+38,986
| +11% | +$365K | ﹤0.01% | 2548 |
|
|
2014
Q4 | $3.91M | Buy |
339,370
+71,040
| +26% | +$702K | ﹤0.01% | 2531 |
|
|
2014
Q3 | $1.91M | Buy |
268,330
+30,165
| +13% | +$210K | ﹤0.01% | 3025 |
|
|
2014
Q2 | $1.69M | Buy |
238,165
+61,040
| +34% | +$357K | ﹤0.01% | 3108 |
|
|
2014
Q1 | $1.08M | Buy |
177,125
+15,529
| +10% | +$114K | ﹤0.01% | 3435 |
|
|
2013
Q4 | $1.41M | Sell |
161,596
-471,813
| -74% | -$2.89M | ﹤0.01% | 3179 |
|
|
2013
Q3 | $2.64M | Buy |
633,409
+632,709
| +90,387% | +$3.49M | ﹤0.01% | 2691 |
|
|
2013
Q2 | $5K | Buy |
+700
| New | +$4.89K | ﹤0.01% | 5215 |
|
Other funds holding MDXG
EWM
TI
VCM
PCMI
NCM
FLAM
Wells Fargo's MDXG Position: Q1 2026 in Review
Wells Fargo reduced its MiMedx Group (MDXG) stake by 54% in Q1 2026, selling an estimated $366K and leaving 62,724 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #4580.
Wells Fargo first reported a position in MDXG in Q2 2013 and has held it in 44 quarters since. The position peaked at $12M in Q4 2017. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.
- Wells Fargo held 62,724 shares of MiMedx Group worth $248K as of Q1 2026.
- Wells Fargo sold 72,680 MiMedx Group shares in Q1 2026, an estimated $366K.
- MiMedx Group made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4580 holding.
- Wells Fargo first reported a position in MiMedx Group in Q2 2013 and has held it in 44 quarters since.
- Wells Fargo's MiMedx Group position peaked at $12M in Q4 2017.
- 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.